In 2017, Dr. Nouredine Sadeg created I-MITOX (International Medical Institute of Toxicology and Pharmacology) and structured it around four key pharmaco-toxicological activities: forensics, clinical analysis, professional toxicology, and research on hair pollutants.
I-MITOX has a high-performance laboratory with instrumentation suited for LC-MS-QTOF, ICP-MS, and HS-GC-MS, as well as a team of forensic experts, specialized doctors, engineers, and biotechnologists. I-MITOX does interesting and innovative work on multiple scientific fronts. Among these, the field of drug treatment occupies an important place.
“The Mitra® device allows doctors to perform accurate blood sampling in a simple, fast, and non-invasive manner,” says Florent Brousse, I-MITOX co-founder and manager. “With Mitra® devices, doctors do the sampling themselves in their offices and send them directly to the laboratory. This avoids having to send the patient to a laboratory for sampling, with the risk that this will never be done.”
Using state-of-the-art tools, including Mitra® devices, I-MITOX is creating a new model for toxicology screening. “Our work is based on quality processes that make it possible to achieve high-performance results,” says Brousse, citing “easy sampling and sending with Mitra® devices and fast, specific, and sensitive analyses in our laboratory.
We also attach great importance to the interpretation of our results and exchange with healthcare professionals. Our work will provide physicians with an efficient and rapid adaptation of their patients’ treatment.
“We are also starting to use the Mitra® with VAMS® system in our professional toxicology activity, enabling us to set up a prevention plan and ensure effective control of additive conduct of personnel in high-risk positions,” says Brousse.